ARCHIVES

IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

NCAB Honors Member Who Was In Stockholm

December 9, 1988

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Possible Association Between Agent Orange, AML, IOM Says.

April 27, 2001

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

NCI To Invite Unaffiliated Oncologists To Enroll Patients On Phase III Trials

May 10, 2002